Immunome (IMNM) Net Equity Issued and Repurchased (2020 - 2025)
Immunome (IMNM) posted Net Equity Issued and Repurchased of $432400.0 for Q4 2025, down 99.04% on a QoQ basis from $44.9 million in Q3 2025, and down 97.84% year-over-year from $20.0 million in Q4 2024.
Immunome (IMNM) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Immunome's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $432400.0 for Q4 2025.
- Quarterly Net Equity Issued and Repurchased fell 97.84% year-over-year to $432400.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.3 million (down 54.94% YoY) and the FY2025 annual result came in at $45.9 million, up 129.48% from the prior year.
- Net Equity Issued and Repurchased was $432400.0 for Q4 2025 at Immunome, down from $44.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $125.0 million in Q2 2023 and bottomed at $34000.0 in Q1 2023.
- A 4-year average of $27.3 million and a median of $801000.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased plunged 89.45% — and 2025, when it plunged 97.84%.
- Immunome's Net Equity Issued and Repurchased stood at $801000.0 in 2021, then soared by 15505.49% to $125.0 million in 2023, then sank by 84.0% to $20.0 million in 2024, then plunged by 97.84% to $432400.0 in 2025.
- Business Quant data shows IMNM's Net Equity Issued and Repurchased at $432400.0 in Q4 2025, $44.9 million in Q3 2025, and $20.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 432,400.00 |
| Dec 31, 2025 | 432,400.00 |
| Sep 30, 2025 | 44.90 Mn |
| Sep 30, 2025 | 44.90 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Jun 30, 2023 | 125.00 Mn |
| Jun 30, 2023 | 125.00 Mn |
| Mar 31, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Jun 30, 2021 | 801,000.00 |
| Jun 30, 2021 | 801,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Jun 30, 2020 | 11.00 Mn |
| Jun 30, 2020 | 11.00 Mn |
| Mar 31, 2020 | 995,000.00 |
| Mar 31, 2020 | 995,000.00 |